欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/1006/001
药品名称Cabazitaxel Sandoz 10 mg/ml Concentrate for solution for infusion
活性成分
    • Cabazitaxel monohydrate 10.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Sandoz GmbH
参考成员国 - 产品名称Austria (AT)
Cabazitaxel Sandoz 10 mg/ml - Konzentrat zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
    • Germany (DE)
      Cabazitaxel HEXAL
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Cabazitaxel Sandoz
    • Finland (FI)
    • Lithuania (LT)
      Cabazitaxel Sandoz 10 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      CABAZITAXEL SANDOZ
    • Bulgaria (BG)
      Cabazitaxel Sandoz
    • Czechia (CZ)
      Cabazitaxel Sandoz
    • Romania (RO)
    • Slovenia (SI)
    • Croatia (HR)
      Kabazitaksel Sandoz 10 mg/ml koncentrat za otopinu za infuziju
许可日期2020/09/15
最近更新日期2024/04/29
药物ATC编码
    • L01CD04 cabazitaxel
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase